A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)

Magdalena Hellauer, Stephen Hudson, Julienne Johnson

Research output: Contribution to journalConference Contribution

Abstract

Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy.
Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33% in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation of
patients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulfil these outcomes.
Original languageEnglish
Pages (from-to)206-206
Number of pages1
JournalInternational Journal of Clinical Pharmacy
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2012
EventESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes - Dublin, Ireland
Duration: 19 Oct 2011 → …

Keywords

  • COPD
  • chronic obstructive pumonary disease
  • smoking

Fingerprint Dive into the research topics of 'A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)'. Together they form a unique fingerprint.

  • Cite this